Entrada Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGEntrada Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 21), showing significant lag compared to the market leaders. Earnings contraction of 126% provides fundamental context to the price action. Investors should exercise caution due to high volatility (86% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.78 | +14.11% | ABOVE |
| 50 SMA | $8.83 | -12.32% | BELOW |
| 100 SMA | $10.51 | -26.33% | BELOW |
| 150 SMA | $10.53 | -26.51% | BELOW |
| 200 SMA | $9.49 | -18.47% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TRDA in an uptrend right now?
TRDA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is TRDA overbought or oversold?
TRDA's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.
Is TRDA outperforming the market?
TRDA has a Relative Strength (RS) Rating of 21 out of 99. TRDA is currently lagging the broader market.
Where is TRDA in its 52-week range?
TRDA is trading at $7.74, which is 47% of its 52-week high ($16.45) and 24% above its 52-week low ($4.93).
How volatile is TRDA?
TRDA has a Beta of 1.62 and 52-week volatility of 86%. It's more volatile than the S&P 500 - expect bigger swings.